We discovered that, unlike METTL6, ADH1A was positively related to the response of Fluorouracil, and LCMT1 was negatively correlated to the therapeutic effect of Lenvatinib, indicating that these prognostic-related TRGs may also influence the therapeutic efficacy of HCC. Here, METTL6 is linked to hepatocellular carcinoma.